BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- As the 2023 BIO International Convention (BIO 2023) concluded its four-day run on Thursday (local time), Korean pharmaceutical companies showcased their unwavering dedication to advancing healthcare and solidified their positio
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Samyang Holdings Biopharm Group said it would open a production base for biodegradable suture yarns with an annual production capacity of 100,000 kilometers of yarns in Hungary on June 13.Hungary was considered an optimal produ
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- In today's fast-paced and highly competitive pharmaceutical industry, companies are constantly seeking ways to accelerate innovation and bring new therapies to market.Licensing agreements have become a vital strategy for foster
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Samsung Biologics President and CEO John Rim said the commencement date for the operation of Plant 5 has been rescheduled to April 2025, five months earlier than the initial target of September 2025.Samsung Biologics has emerge
BOSTON, Mass. – By Lee Han-soo/Korea Biomedical Review correspondent – After a prolonged period of uncertainty and disruption caused by the Covid-19 pandemic, the biotechnology industry is experiencing a remarkable resurgence.The 2023 BIO International Convention kicked off its four-day run at the B
Shaperon, a Korean biopharmaceutical company developing innovative immune therapeutics, announced that it would embark on global expansion by showcasing its proprietary inflammatory complex inhibition technology at the 2023 BIO International Convention, to be held in Boston, the U.S., from June 5 to
EuBiologics, the world's No. 1 cholera vaccine manufacturer, said it will seek global partners by promoting its proprietary vaccine manufacturing technology, products and platform at the 2023 BIO International Convention (BIO 2023), to be held in Boston, the U.S., from June 5 to 8.EuBiologics is the
A business enterprise recently announced its participation in ASCO 2023 (American Society of Clinical Oncology 2023) and BIO 2023 (BIO International Convention 2023), throwing its gauntlet in the biopharmaceutical industry. Axceso Biopharma, a new drug developer, is the company.Starting as a cosmeti
Lotte Group's foray into the contract development and manufacturing organization (CDMO) business has gained significant traction since its inception in June 2022 with the establishment of Lotte Biologics. Now, one year later, the company has solidified its position in the industry by taking over a b
Dong-A ST, which aims to become a global bio company, plans to participate in the 2023 BIO International Convention, to be held in Boston, U.S. ,from June 5 to 8.During the convention, the company will showcase its significant R&D pipeline.As one of Korea's leading pharmaceutical and biotechnology c
Samsung Biologics said it will participate in the 2023 BIO International Convention next month. The BIO International Convention is an event organized by the Biotechnology Innovation Organization (BIO) and held annually in major cities with bioclusters in the U.S. The convention serves as an exchang
The Prestige Biopharma Group said Thursday that it would participate in BIO International Convention 2023, the largest international biopharmaceutical event in Boston, Mass., from June 5 to 8.Prestige Biopharma Chairwoman Park So-yeon and Prestige Biologics CEO Hyun Deok-hun will attend the event, o
CHA Biomedical Group announced on Wednesday it will participate in the world's largest bio exhibition, 2023 BIO International Convention, to be be held in Boston, from June 5 to 9.Affiliates of CHA Biomedical Group -- Matica Biotechnology, CHA Biotech, and CHA Vaccine Research Institute -- will expl
Amid the mounting anticipation for the BIO International Convention 2023, Korean contract development and manufacturing organization (CDMO) companies are strategically positioning themselves to reinforce their stature as global frontrunners in the industry.According to industry officials, Samsung Bi
With the “BIO International Convention 2023” two weeks away, providing a battleground for pharmaceutical and biotech companies worldwide, attention is on the Korean companies that have thrown their hats into the ring.BIO 2023 is the world’s largest comprehensive biotechnology convention attended by